October 25, 2007 16:40 ET

Ad hoc: Q-Cells AG: Partners in EverQ approve significant capacity expansion - company prepares for IPO

Bitterfeld-Wolfen--(Marketwire - October 25, 2007) - Q-Cells AG (QCE; ISIN DE0005558662) and its partners in the Joint Venture EverQ GmbH - Evergreen Solar, Inc. and REC Renewable Energy Corporation ASA - have approved significant expansion plans for EverQ.

EverQ will build a third integrated wafer, cell and module production facility at its company site in Bitterfeld-Wolfen (Germany). The new EverQ facility will increase EverQ's production capacity from 100 MWp to 180 MWp. The partners will invest nearly EUR 150 million in the new EverQ III facility, which is expected to start production in the first quarter of 2009. The new EverQ facility will use Evergreen Solar's Quad furnace technology.

To support the further growth ambitions of EverQ, REC has offered an additional supply agreement for polysilicon which should enable EverQ to increase its production capacity to 600 MWp by the year 2012. The supply agreement totals approximately 4,000 MT delivered at market terms. Annual shipments under the new agreement will peak at slightly more than 700 MT and will run from 2010 until 2015. Total Polysilicon volumes supplied by REC to EverQ under the existing and new agreements could potentially reach 2,100 MT per year.

Q-Cells and its partners, Evergreen Solar and REC, have also agreed to start preparations for an IPO of EverQ immediately. The final timing of the IPO is still to be decided. As part of the preparations for the IPO, the management and organization of EverQ will be significantly strengthened to enable the transformation of EverQ into an independent company with its own branding. The sales and marketing organization will be expanded as modules will be distributed under the new brand in the future.

To secure the independent development, EverQ has a proprietary right to the current technology base of Evergreen and will have a right to license all new material technology development by Evergreen on the String Ribbon™ platform over the 5 years following the IPO. EverQ will also build a strong R&D team to complement this access to new technology with own improvements.

Additional Information: ISIN: DE0005558662 Listing: Amtlicher Markt / Prime Standard; Frankfurter Wertpapierbörse (Official Market / Prime Standard; Frankfurt Stock Exchange) Company's seat: Federal Republic of Germany

Q-Cells Aktiengesellschaft Stefan Lissner Head of Investor Relations Guardianstraße 16 OT Thalheim 06766 Bitterfeld-Wolfen Germany Phone: +49 - (0)3494 - 6699 10101

Copyright © Hugin ASA 2007. All rights reserved.

Contact Information